Hongqiu Zhu

Dr. Hongqiu Zhu

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MLMin Liu
Min Liu
HZHongqiu Zhu
Hongqiu Zhu
YZYing Zhu
Ying Zhu
XHXiaodan Hu
Xiaodan Hu

27 August 2020 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
YZYing Zhu
Ying Zhu
YLYin Li
Yin Li
MLMin Liu
Min Liu
XHXiaoDan Hu
XiaoDan Hu
HZHongqiu Zhu
Hongqiu Zhu
Polycystic ovary syndrome (PCOS) is a common endocrine disease with reproductive dysfunction and metabolic disorder in women of childbearing age. Gastrointestinal microbiome contributes to PCOS through mediating insulin resistance. Guizhi Fuling Wan, Chinese herbal medicine, can treat PCOS with insulin resistance (PCOS-IR), but the underlying mechanism is not clear. The aim of this study was to characterize the exact mechanism of Guizhi Fuling Wan action and whether it is related to the regulation of intestinal flora structure. We induced PCOS-IR rat model by means of letrozole sodium carboxymethyl cellulose (CMC-na) solution combined with high-fat emulsion administration and randomly divided it into blank control group (K), model control group (M), low dose of Guizhi Fuling Wan group (D), middle dose of Guizhi Fuling Wan group (Z), high dose of Guizhi Fuling Wan group (G) and positive drug (Metformin) control group (Y). After 36 days of modeling and treatment, serum and stool samples from all rats were collected for a follow-up analysis. The data display that, compared with K group, elevated testosterone and HOMA-IR, turbulent estrous cycles and polycystic ovaries in M group, indicating the PCOS-IR rat model is successfully established. Increased fasting insulin is associated with higher inflammation(plasma TNF-α, IL-6, and HS-CPR concentration were determined) in M group, and the altered intestinal flora (compared with the K group, in M group the relative abundance of Alloprevotella was decreased significantly, while the relative abundance of Lachnospiraceae UCG-008, Lachnospiraceae NK4A136, Lactobacillus, Ruminiclostridium 9, and Ruminococcaceae UCG-003 was increased significantly) induced the secretion of inflammatory markers. On the other hand, Guizhi Fuling Wan can alleviate inflammation, improve insulin resistence: Lower inflammation decreased fasting insulin can be seen in G group compared with M group, this effect is related to the regulating effect of Guizhi Fuling Wan on intestinal flora (in G group, the relative abundance of Alloprevotella, Ruminococcaceae UCG-003, and Lachnospiraceae UCG-008 was increased significantly, compared with M group). This research demonstrates Guizhi Fuling Wan improve insulin resistance in polycystic ovary syndrome with the underlying mechanism of regulating intestinal flora to control inflammation. It would be useful to promote the therapeutic effect of Guizhi Fuling Wan on PCOS-IR.

20 September 2023 in Microbial Pathogenesis
Verified
Journal Article
Closed access
YZYuanyuan Zou
Yuanyuan Zou
RLRuoyuan Liao
Ruoyuan Liao
RCRui Cheng
Rui Cheng
HCHuiyee Chung
Huiyee Chung
HZHongqiu Zhu
Hongqiu Zhu
YHYefang Huang
Yefang Huang

15 May 2023 in Gynecological Endocrinology
Verified
Journal Article
Open access
PWPeijuan Wu
Peijuan Wu
YZYing Zhu
Ying Zhu
JLJunjie Li
Junjie Li
HCHaiyan Chen
Haiyan Chen
HWHanxue Wu
Hanxue Wu
HZHongqiu Zhu
Hongqiu Zhu
To investigate the potential molecular mechanism of traditional Chinese medicine Guizhi Fuling Wan (GZFLW) inhibiting granulosa cells (GCs) autophagy in polycystic ovary syndrome (PCOS). Control GCs and model GCs were cultured and treated with blank serum or GZFLW-containing serum. The levels of H19 and miR-29b-3p in GCs were detected using qRT-PCR, target genes of miR-29b-3p were identified using luciferase assay. The protein expressions of Phosphatase and tensin homolog (PTEN), Matrix Metalloproteinase (MMP)-2, and Bax were measured using western blot. The level of autophagy was detected via MDC staining, the degree of autophagosomes and autophagic polymers was observed using dual fluorescence-tagged mRFP-eGFP-LC3. GZFLW intervention reduced the expression of autophagy-related proteins PTEN, MMP-2 and Bax, by upregulating the expression of miR-29b-3p and downregulated the expression of H19 (p < .05 or p < .01). The number of autophagosomes and autophagy polymers was significantly decreased by GZFLW treatment. However, the inhibition of miR-29b-3p and overexpression of H19 induced a significant increase in the number of autophagosomes and autophagic polymers, which attenuated the inhibitory effect of GZFLW on autophagy (p < .05 or p < .01). In addition, inhibition of miR-29b-3p or overexpression of H19 can attenuate the effect of GZFLW on the expression of PTEN, MMP-2 and Bax proteins (p < .05 or p < .01). Our study found that GZFLW inhibits autophagy in PCOS GCs via H19/miR-29b-3p pathway.

1 May 2020 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
MLMin Liu
Min Liu
HZHongqiu Zhu
Hongqiu Zhu
YLYin Li
Yin Li
JZJing Zhuang
Jing Zhuang
TCTing Cao
Ting Cao
YWYi Wang
Yi Wang
Long non-coding RNA X-inactive specific transcript (LncRNA Xist) plays a pivotal role in various types of human diseases, while its involvement in polycystic ovary syndrome (PCOS) remains unknown. In the study we aimed to investigate if downregulate Xist expression is involved in PCOS and is correlated with adverse pregnant outcomes in PCOS. In this study, expression of lncRNA Xist in peripheral blood collected from both PCOS patients and controls were detected by qRT-PCR. Diagnostic values of Xist expression for PCOS were evaluated by ROC curve analysis. Correlation between Xist expression and pregnant outcomes of PCOS patients was analyzed. Compared with controls, Xist was significantly downregulated in patients with PCOS but not in patients with other types of diseases. Xist expression can be used to effectively distinguish PCOS patients from controls. Reduced expression level of Xist was significantly correlated with adverse pregnant outcomes of PCOS patients but not healthy controls. The downregulation of Xist expression may be involved in PCOS and is correlated with adverse pregnant outcomes in PCOS.

13 November 2020 in Medicine
Verified
Journal Article
Open access
MLMin Mm Liu
Min Mm Liu
HZHongqiu Zhu
Hongqiu Zhu
XHXiaodan Mm Hu
Xiaodan Mm Hu
YZYing Mm Zhu
Ying Mm Zhu
HCHaiyan Mm Chen
Haiyan Mm Chen
Background: Polycystic ovary syndrome (PCOS) is one of the common gynecological endocrine system diseases. It is characterized by excessive androgen, rare or anovulation, and polycystic ovary morphology. Coenzyme Q10 (CoQ10) is a fat-soluble natural vitamin, which has a continuous oxidation-reduction cycle and is an effective antioxidant that can protect ovaries from oxidative damage. This study aims to systematically summarize and analyze the scientific literatures on glucose metabolism index, lipid profiles, inflammatory factor, and sex hormone level of PCOS patients treated with CoQ10 to provide a reference basis for clinical treatment. Methods: We will retrieve the following electronic databases from the built-in until March 2021: Cochrane Library, PubMed, EMBASE, Web of Science, China National Knowledge Infrastructure (CNKI), Chinese Biomedical Literature Database (CBM), Clinical Trials. gov, Chinese Scientific Journal Database (VIP), and Wang-fang database. Two reviewers will independently scan the articles searched, de-duplication, filtering, quality assessment. Differences will be resolved by discussion between the 2 reviewers or by a third reviewers. All analyses were systematic to evaluate interventions based on the Cochrane handbook. Meta-analysis and/or subgroup analysis will be performed on the basis of the included studies. Discussion: This review will be to investigate the efficacy of CoQ10 supplementation on glucose metabolism, lipid profiles, and biomarkers of inflammation in women with PCOS and provide a high-quality synthesis to assess whether CoQ10 is an effective and safe intervention for PCOS. The results of the analysis will be published in a scientific journal after peer-review. Systematic review registration: INPLASY 2020100013.